Mukka Proteins valuation

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024
Price multiples — at each FY-end close
10.71×———
1.48×———
0.42×———
Enterprise multiples
0.86×———
10.30×———
11.74×———
Yield
9.3%———
−31.3%———
Reference — adjusted share basis
₹24.68———
₹2.30₹1.74₹1.55₹2.34
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MUKKA₹24.68

Mukka Proteins Limited

· FMCG & Retail
₹ CrorePeersNARMADAKSEMcap ₹740 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Price Multiples — at each FY-end close
P/E———10.71
P/B———1.48
P/Sales———0.42
Enterprise Multiples
EV/Sales———0.86
EV/EBITDA———10.30
EV/EBIT———11.74
Yield
Earnings Yield %———9.34
FCF Yield %———-31.31
Reference — adjusted share basis
Price (FY-end close, adj.)———24.68
EPS (adj.)2.341.551.742.30
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.